A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic‐resistant Pseudomonas aeruginosa; a preliminary report of efficacy

By A. Wright, C. Hawkins, E. Änggård, D. Harper. Clinical Otolaryngology, 2009

879 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The Hologenome Concept: Human, Animal and Plant Microbiota (2014, background): “, Giovannoni, S. J., et al. (1986). Microbial ecology and evolution: A ribosomal RNA approach. Annual Review of Microbiology, 40, 337–365. Palmer, C., Bik, E. M., DiGiulio, D. B., et al. (2007). Development of the human infant intestinal microbiota.”
Phage cocktails and the future of phage therapy. (2013, background): “is particularly noteworthy because it is the first controlled double-blind Phase I/II clinical trial for a phage cocktail [44].”
Phage therapy in clinical practice: treatment of human infections. (2010, background): “worked closely with the British regulatory bodies throughout [66].”
Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It (2020, background): “So far, there are only a few reports on the clinical use of bacteriophages [58,61].”
Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection (2017, background): “and/or safety in the current medical literature (relevant examples include (10-18)).”